Contact this trialFirst, we need to learn more about you.
Procedure
Lovastatin + Pembrolizumab for Head and Neck Cancer
Recruiting1 awardPhase 2
Atlanta, Georgia
"This trial is testing a combination of lovastatin, a drug that lowers cholesterol and may cause tumor cell death, and pembrolizumab, an immunotherapy drug, to treat patients with head
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service